A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Cornyn Reintroduce the GENE Act, Countering CCP Threat to Collect Genomic Data
The genomic data of American citizens has been aggressively sought after by the Chinese Communist Party (CCP) through both legal and illegal means. The U.S. must advance its security in order to avoid risking any data being vulnerable to international influence.
U.S. Senators Marco Rubio (R-FL) and John Cornyn (R-TX) reintroduced the Genomics Expenditures and National Security Enhancement (GENE) Act to counter the growing threat caused by the CCP.
-
“There is no reason for our lack of oversight on access to American citizens’ genomic data. It’s imperative that Congress has a seat at the table to confront this growing national security and privacy threat.” – Senator Rubio
-
“For too long, the People’s Republic of China has collected Americans’ healthcare data without anywhere near sufficient scrutiny. This legislation would confront this growing national security threat and ensure private genetic information doesn’t fall into the wrong hands.” – Senator Cornyn
Specifically, this bill:
-
Increases congressional oversight by requiring the Committee on Foreign Investment in the United States (CFIUS) to include the Senate Select Committee on Intelligence and Senate Committee on Foreign Relations in its briefings.
-
Directs CFIUS to rewrite its regulations to require mandatory filing for any deal that involves a company working with genetic information.
-
Requires that the U.S. Department of Health and Human Services (HHS) be consulted on any deal that involves a genetic data transaction, to increase cross-agency awareness of transactions of concern.
Want more information?